
Robert A. Zeman
Examiner (ID: 12430, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1326 |
| Issued Applications | 557 |
| Pending Applications | 268 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17609905
[patent_doc_number] => 20220152184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 17/488545
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488545 | VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE | Sep 28, 2021 | Pending |
Array
(
[id] => 18806926
[patent_doc_number] => 20230381259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => DEVELOPMENT OF BIOCONVERSION PROCESS FOR FUNCTIONAL BLACK SOYBEAN POWDER BIOCONVERTED USING ENZYME GROUP DERIVED FROM BACILLUS BACTERIA AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/027619
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027619
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027619 | DEVELOPMENT OF BIOCONVERSION PROCESS FOR FUNCTIONAL BLACK SOYBEAN POWDER BIOCONVERTED USING ENZYME GROUP DERIVED FROM BACILLUS BACTERIA AND USE THEREOF | Sep 22, 2021 | Pending |
Array
(
[id] => 18806918
[patent_doc_number] => 20230381251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => NOVEL LACTIC ACID BACTERIA ISOLATED FROM AGED MEAT, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/027614
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027614 | NOVEL LACTIC ACID BACTERIA ISOLATED FROM AGED MEAT, AND USE THEREOF | Sep 22, 2021 | Pending |
Array
(
[id] => 18806140
[patent_doc_number] => 20230380469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => COMPOSITION CONTAINING FUNCTIONAL BLACK SOYBEAN POWDER BIOCONVERTED BY USING BACILLUS ENZYMES AS ACTIVE INGREDIENT, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/027621
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027621 | COMPOSITION CONTAINING FUNCTIONAL BLACK SOYBEAN POWDER BIOCONVERTED BY USING BACILLUS ENZYMES AS ACTIVE INGREDIENT, AND USE THEREOF | Sep 22, 2021 | Pending |
Array
(
[id] => 19135596
[patent_doc_number] => 11970527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Antibody directed against
[patent_app_type] => utility
[patent_app_number] => 17/483162
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 55
[patent_no_of_words] => 17642
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483162 | Antibody directed against | Sep 22, 2021 | Issued |
Array
(
[id] => 19281913
[patent_doc_number] => 20240218387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => CHLORELLA-BASED PRODUCTION OF EXTRACELLULAR VESICLE-EMBEDDED SMALL RNAs FOR PROPHYLACTIC OR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/044868
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044868
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044868 | CHLORELLA-BASED PRODUCTION OF EXTRACELLULAR VESICLE-EMBEDDED SMALL RNAs FOR PROPHYLACTIC OR THERAPEUTIC APPLICATIONS | Sep 12, 2021 | Pending |
Array
(
[id] => 18672861
[patent_doc_number] => 20230310307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMPOSITION FOR USE IN FOOD SUPPLEMENTS AND/OR COSMETIC PRODUCTS, COMPRISING BACILLUS SUBTILIS
[patent_app_type] => utility
[patent_app_number] => 18/024917
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024917 | COMPOSITION FOR USE IN FOOD SUPPLEMENTS AND/OR COSMETIC PRODUCTS, COMPRISING BACILLUS SUBTILIS | Sep 1, 2021 | Pending |
Array
(
[id] => 17685924
[patent_doc_number] => 20220193216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => HELICOBACTER THERAPEUTIC
[patent_app_type] => utility
[patent_app_number] => 17/459715
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459715 | Helicobacter therapeutic | Aug 26, 2021 | Issued |
Array
(
[id] => 17215757
[patent_doc_number] => 20210349095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ROS KINASE IN LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 17/377475
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/377475 | ROS KINASE IN LUNG CANCER | Jul 15, 2021 | Abandoned |
Array
(
[id] => 17183833
[patent_doc_number] => 20210330718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOSITION AND METHODS FOR TREATING CANCER AND IMMUNE DISORDERS USING VEILLONELLA BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/368396
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368396 | COMPOSITION AND METHODS FOR TREATING CANCER AND IMMUNE DISORDERS USING VEILLONELLA BACTERIA | Jul 5, 2021 | Abandoned |
Array
(
[id] => 17356782
[patent_doc_number] => 20220017578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/367812
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367812 | Immunogenic compositions comprising | Jul 5, 2021 | Issued |
Array
(
[id] => 18537501
[patent_doc_number] => 20230242595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => ADAS COMPRISING BACTERIAL SECRETION SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/011008
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011008
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011008 | ADAS COMPRISING BACTERIAL SECRETION SYSTEMS | Jun 16, 2021 | Pending |
Array
(
[id] => 17336024
[patent_doc_number] => 20220002355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/346362
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346362
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346362 | Modified meningococcal fHbp polypeptides | Jun 13, 2021 | Issued |
Array
(
[id] => 17414325
[patent_doc_number] => 20220049229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => VACCINE FOR IMMUNOCOMPROMISED HOSTS
[patent_app_type] => utility
[patent_app_number] => 17/331536
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331536 | Vaccine for immunocompromised hosts | May 25, 2021 | Issued |
Array
(
[id] => 18234221
[patent_doc_number] => 11598773
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-03-07
[patent_title] => Rapid analysis of cyanobacterial toxins
[patent_app_type] => utility
[patent_app_number] => 17/324606
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 12008
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324606 | Rapid analysis of cyanobacterial toxins | May 18, 2021 | Issued |
Array
(
[id] => 18421587
[patent_doc_number] => 20230176050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Methods for Verification of Drug Levels Using Dried Blood Samples
[patent_app_type] => utility
[patent_app_number] => 17/924064
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924064 | Methods for Verification of Drug Levels Using Dried Blood Samples | May 17, 2021 | Pending |
Array
(
[id] => 17256846
[patent_doc_number] => 20210369831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => CLOSTRIDIUM DIFFICILE MULTI-COMPONENT VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/321719
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17321719
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/321719 | CLOSTRIDIUM DIFFICILE MULTI-COMPONENT VACCINE | May 16, 2021 | Abandoned |
Array
(
[id] => 17201382
[patent_doc_number] => 20210341477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Compositions, Methods, and Systems for Detecting Methicillin-Resistant Staphylococcus Aureus
[patent_app_type] => utility
[patent_app_number] => 17/245584
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245584 | Compositions, Methods, and Systems for Detecting Methicillin-Resistant Staphylococcus Aureus | Apr 29, 2021 | Pending |
Array
(
[id] => 18636209
[patent_doc_number] => 11760794
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use
[patent_app_type] => utility
[patent_app_number] => 17/243455
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 49
[patent_no_of_words] => 35463
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/243455 | Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use | Apr 27, 2021 | Issued |
Array
(
[id] => 17036692
[patent_doc_number] => 20210253650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SECONDARY TUBERCULOSIS AND NONTUBERCULOUS MYCOBACTERIUM INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/241494
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241494 | COMPOSITIONS AND METHODS FOR TREATING SECONDARY TUBERCULOSIS AND NONTUBERCULOUS MYCOBACTERIUM INFECTIONS | Apr 26, 2021 | Abandoned |